CompaniesCorino Therapeutics

Corino Therapeutics

active
Charlottesville, NC, United States
Founded 2016
Website
About

Acquisition & Development

Areas of Focus

Categories

Small Molecule PharmaceuticalNorth & South Carolina
Clinical Trials (3)
View all

Total Trials

3

As Lead Sponsor

2

As Collaborator

1

Total Enrollment

72

By Phase

PHASE1: 2EARLY_PHASE1: 1

By Status

COMPLETED: 2RECRUITING: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
NCT06326502
Hover over trial bars to see details

Recent Trials

NCT06326502Lead Sponsor
A Safety and Efficacy Study of Multiple Tyrosine Kinase Inhibitor Drug (ETN101) in Advanced Hepatocellular Carcinoma
PHASE1Recruiting
50 participants
Started: Feb 7, 2024 · Completed: Jun 7, 2027
NCT03591757Collaborator
Short-term Effects of TOLCAPONE on Transthyretin Stability in Subjects With Leptomeningeal TTR Amyloidosis (ATTR)
EARLY_PHASE1Completed
10 participants
Started: Oct 30, 2018 · Completed: Apr 26, 2019
NCT03633591Lead Sponsor
A Study Assessing the Safety and Pharmacokinetic Profile of Modified Release Formulations of Tolcapone
PHASE1Completed
12 participants
Started: Jun 25, 2018 · Completed: Oct 22, 2018
Funding History (1)
D
Apr 27, 2017
Filing
Locations (1)
Headquarters
Charlottesville, NC, United States
Map

Loading map...